The SM Journey: Living
Find out what’s new and what’s next in treatment options for SM.
-
-
Patient outcomes in MCL remain poor despite therapeutic advancements
-
What is hereditary alpha-tryptasemia, and how does it relate to SM?
-
SM treatment has improved, but more therapies are needed for rare subtypes
-
Researchers highlight complex mutational profile of SM-AHN
-
My support dog is always there for me. Now it’s my turn to be there for him
-
People with SM may face higher risk of skin cancer, study finds
